?

Susman Sally

Executive Vice President
Pfizer Inc.
US, New York [HQ]
CIK 1263544

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
2,181,480,000
Price per Share :
$26.49
Equivalence :
$57,787,405,200.00

Transaction History

  • M
    Form 4
    2,181,480,000 Shares After Transaction
    Value : $59,641,663,200.00
    $17,453,035,800.00
    02/23/24
  • Footnotes:
    #1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
    #2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
    #3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
    #4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • F
    Form 4
    2,132,000,000 Shares After Transaction
    Value : $59,184,320,000.00
    $1,373,564,800.00
    02/23/24
  • F
    Form 4
    1,616,110,000 Shares After Transaction
    Value : $44,232,930,700.00
    $14,119,909,300.00
    02/23/24